Joint collaboration enables clinical flow cytometry data analysis

Jan. 2, 2014
Quartz Bio SA, the SIB Swiss Institute of Bioinformatics, and Geneva Bioinformatics SA (GeneBio), have developed a platform for the analysis of flow cytometry data.

Quartz Bio SA, the SIB Swiss Institute of Bioinformatics (both in Lausanne, Switzerland), and Geneva Bioinformatics SA (GeneBio; Geneva, Switzerland), have developed a platform for the analysis of flow cytometry data. Dubbed MegaClust, the platform provides unprecedented, unbiased, in-depth data analysis in order to assess the safety and efficacy of drugs in clinical trials and identify biomarkers for patient stratification. Until now, such analysis was a hurdle for pharmaceutical companies and clinical research organizations, as clinical flow cytometry experiments generally contain a large number of samples collected from multiple sources, making curation and manual analysis time-consuming, not systematic, and therefore error-prone.

Related: Flow cytometry: Instruments, components, and impact

MegaClust enables automated, unbiased, and thorough identification of phenotypically similar cell populations in large datasets consisting of many samples. The technology allows reliable, quantitative cross-sample analyses and therefore provides a very powerful tool to stratify individuals and/or to analyze variations in cell subpopulations upon stimulations and candidate treatments.

Jérôme Wojcik, founder and CEO of Quartz Bio, says that “MegaClust achieved comparable quality as manual gating strategies and was in addition capable of identifying additional quality control problems undetected by classical approaches. We believe that the automated and systematic quality control of all files of a flow cytometry experiment enabled by MegaClust is the first instrumental step for a high-quality analysis. For those reasons, we are excited to keep collaborating with SIB and GeneBio in order to support our customer’s Precision Medicine projects with MegaClust."

The collaboration, which began in early 2013, brings together Quartz Bio’s expertise in clinical data analysis and the SIB's bioinformatics expertise. MegaClust is financially supported by the Commission for Technology and Innovation (KTI/CTI), the innovation promotion agency of the Swiss Confederation.

------

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!